FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10147411000001103: Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32178501000001112 Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
50500501000001112 Antacid & Oxetacaine oral suspension (Special Order) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Is a Generic Antacid & Oxetacaine oral suspension true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Magnesium hydrate false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Aluminium oxide false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Oxetacaine false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Aluminium oxide false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Aluminium hydroxide false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Aluminium hydroxide true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Oxetacaine false Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Aluminium oxide true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Oxetacaine true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Oxetacaine true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Is pack of False Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Special Order) 1 ml Is pack of False Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Antacid & Oxetacaine oral suspension (Special Order) 1 ml Has AMP True Antacid & Oxetacaine oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start